Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Mounjaro is FDA-approved for Type 2 Diabetes and Zepbound is for chronic weight management
Why are GLP-1 receptor agonists effective for OSA
To qualify, you must be 18, have Medicare Part D (prescription drug coverage) and meet the programs clinical criteria: A BMI of 35 or higher A BMI of 30 or higher and one or more of the following conditions: a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension while on at least two blood pressure medications, or chronic kidney disease stage 3a or above A BMI of 27 or higher and one or more of the following conditions a diagnosis of pre-diabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease Those with type 2 diabetes, moderate to severe obstructive sleep apnea, or MASH (fatty liver disease) are ineligible for the Medicare GLP-1 Bridge program
the Bridge benefit is the same either way
US$ 26.47
US$ 27.36
US$ 22.16
